MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-DL-01-0006047
_PRIVATE_LIMITED.webp)
Bio Vaccines (India) Private Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹55,339
▲ 37% YoY
Net loss · FY 2024
₹24,766
Net margin -44.8%
EBITDA · FY 2024
-₹6,264
EBITDA margin -11.3%
Authorised capital
₹4 Cr
Registered with MCA
Paid-up capital
₹3.9 Cr
Issued & subscribed
Open charges
₹7.55 Cr
Satisfied ₹4.15 Cr
Company age
16 yrs
Est. 2010
Directors on board
2
As per MCA filings
About Bio Vaccines (India) Private Limited
Data last updated:
Bio Vaccines (India) Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 03 August 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24230DL2010PTC265256. Its GSTIN is 23AAECB2087M1ZL (Madhya Pradesh).
The company has an authorised share capital of ₹4 Cr and a paid-up capital of ₹3.9 Cr. It is led by directors Manorma and Urmil Arora.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 1092 Shiv Motor Market Bara Bazar Kashmere Gate, New Delhi, Delhi, India – 110006.
As per the financials filed for FY 2024, the company reported a revenue of ₹55,339, a growth of 37% compared to the previous year. For the same year it recorded a net loss of ₹24,766 (net margin -44.8%) and EBITDA of -₹6,264 (EBITDA margin -11.3%). Revenue has declined at a compounded annual rate (CAGR) of 84% over three years.
As per MCA filings, the company has open charges of ₹7.55 Cr and satisfied charges of ₹4.15 Cr on record.
Bio Vaccines (India) Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-01-0006047). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website biovaccine.co.
Company details
CIN U24230DL2010PTC265256
Registration Number 265256
Incorporation Date 03 August 2010
ROC Delhi
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-DL-01-0006047
CIN history
Bio Vaccines (India) has one previous CIN (Corporate Identification Number): U24230MP2010PTC024056. The current CIN is U24230DL2010PTC265256, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24230DL2010PTC265256 | Current |
| U24230MP2010PTC024056 | Previous |
Key People
Manorma Director Urmil Arora Director Recognitions & Rankings of Bio Vaccines (India)
Contact details
Bio Vaccines (India) Private Limited's registered office is in New Delhi, Delhi. Its website is biovaccine.co. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address1092 Shiv Motor Market Bara Bazar Kashmere Gate, New Delhi, Delhi, India – 110006
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Bio Vaccines (India) Private Limited, buy the company report.
Comprehensive company report
Bio Vaccines (India) Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Bio Vaccines (India) is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Bio Vaccines (India) Private Limited, buy the company report.
Financials of Bio Vaccines (India) Private Limited
FY 2025 filings availableBio Vaccines (India) Private Limited reported revenue of ₹55,339 (up 37% YoY) for FY 2024.
Revenue · FY 2024
₹55,339 ▲ 37%
Net loss · FY 2024
₹24,766 margin -44.8%
EBITDA · FY 2024
-₹6,264 margin -11.3%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 37%
3 years · compounded
▼ 84%
EBITDA CAGR growth
1 year
▼ 86%
3 years · compounded
▲ 95%
Revenue rose 37% in the latest year, though over three years it has declined at a compounded annual rate (CAGR) of 84%. EBITDA fell 86% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹6,264 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹24,766 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -11.3% | ||||
| Net Profit Margin | -44.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Bio Vaccines (India) Private Limited, buy the company report.
Board of directors of Bio Vaccines (India) Private Limited
Bio Vaccines (India) has 2 current directors and 8 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manorma | Director | 08 May 2024 | 2 Years 6 Months | Current |
| Urmil Arora | Director | 03 Sep 2011 | 15 Years 2 Months | Current |
Auditor
Bio Vaccines (India) Private Limited is audited by SANDEEP PARTEEK & CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SANDEEP PARTEEK & CO | FY 2023 | 531316 |
Shareholding
The shareholding of Bio Vaccines (India) Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2021 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Bio Vaccines (India) Private Limited, buy the company report.
Charges & borrowings
Open charges
₹7.55 Cr
Satisfied charges
₹4.15 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 14 Aug 2013 | 10452176 | State Bank of India | ₹7.55 Cr | Open | |
| 01 Dec 2010 | 10257383 | Punjab National Bank | ₹4.15 Cr | Satisfied |
To see the full charge records of Bio Vaccines (India) Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Bio Vaccines (India) Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Bio Vaccines (India) Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Bio Vaccines (India) has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AAECB2087M1ZL | Madhya Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Bio Vaccines (India) Private Limited, buy the company report.
Recent activity
Bio Vaccines (India) Private Limited has 10 board changes on record since 2011: 2 appointments and 8 cessations. The latest: Tanuj Arora ceased to be Director on 09 May 2024.
AGM
Bio Vaccines (India) Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Bio Vaccines (India) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Ceased
Tanuj Arora ceased to be Director.
Appointed
Manorma was appointed as Director.
Charges
A charge with State Bank Of India of Rs. 7.55 Cr registered on 14 Aug 2013 with Charge ID 10452176 was modified on 17 Aug 2019.
Ceased
Jugal Kishore Sagar ceased to be Managing Director.
Charges
A charge with State Bank Of India amounted to Rs. 7.55 Cr with Charge ID 10452176 was registered on 14 Aug 2013.
Charges
A charge registered on 01 Dec 2010 via Charge ID 10257383 with Punjab National Bank was fully satisfied on 12 Jan 2013.
Ceased
Puneet Sagar ceased to be Director.
Ceased
Varun Sagar ceased to be Director.
Ceased
Yogesh Mehta ceased to be Director.
Ceased
Urmil Arora ceased to be Additional Director.
5 earlier events are in the company report.
Frequently asked questions
Bio Vaccines (India) is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 03 August 2010 (16+ years old) and is registered under CIN U24230DL2010PTC265256.
Bio Vaccines (India) has 2 current directors:
- Manorma - Director
- Urmil Arora - Director
The latest financial statements of Bio Vaccines (India) on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Bio Vaccines (India) is 23AAECB2087M1ZL, registered in Madhya Pradesh.
The CIN (Corporate Identification Number) of Bio Vaccines (India) is U24230DL2010PTC265256. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Bio Vaccines (India) was incorporated on 03 August 2010, making it 16+ years old. It is registered with the Registrar of Companies, Delhi.
Tanuj Arora ceased to be Director on 09 May 2024. Manorma was appointed as Director on 08 May 2024. Jugal Kishore Sagar ceased to be Managing Director on 31 Mar 2015. Bio Vaccines (India) has 10 board changes on record in total.
Yes, Bio Vaccines (India) is registered as a small enterprise under Udyam registration (number: UDYAM-DL-01-0006047).
Bio Vaccines (India) can be reached through the website biovaccine.co. Its registered office is in New Delhi, Delhi, India.
The registered office of Bio Vaccines (India) is at 1092 Shiv Motor Market Bara Bazar Kashmere Gate, New Delhi, Delhi, India – 110006.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages